Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

Adenoid cystic carcinoma of the head and neck

(2012) Christopher L. Ellington et al.   CANCER

A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC

(2011) N. G. Chau et al.   ANNALS OF ONCOLOGY

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

(2011) Athanassios Argiris et al.   CANCER

Molecular biology of adenoid cystic carcinoma

(2011) Jia Liu et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Salivary gland carcinoma in Denmark 1990–2005: A national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)

(2011) Kristine Bjørndal et al.   ORAL ONCOLOGY

Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma

(2010) Niladri Ghosal et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review

(2010) Giorgos Papaspyrou et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

(2010) Stephen K. Williamson et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting the RAF–MEK–ERK pathway in cancer therapy

(2009) Clara Montagut et al.   CANCER LETTERS

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors

(2008) L. Dal Lago et al.   ONCOLOGIST

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

(2008) L.D. Locati et al.   ORAL ONCOLOGY